PE-Backed Biotech Co. UniQure Eyes $75M IPO

Dutch biotech company uniQure plans to make a U.S. public offering to raise up to $75 million in capital, according to U.S. Securities and Exchange Commission filings Thursday....

Already a subscriber? Click here to view full article